
The general public will subscribe 6.25 million shares, 25 percent of the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike price of Rs 77.
The general public can subscribe the IPO on 2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the case of e-IPO, the process continues for 24 hours.
BF Biosciences IPO Receives Overwhelming Response from Investors
The book-building phase of BF Biosciences concluded last week with an oversubscription of 3.4 times.
The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and raised Rs 1.93 billion.
Shahid Ali, CEO Arif Habib Limited said that investing in the public offering of BF Biosciences presents a decent opportunity for retail investors to engage with a fundamentally strong company at a more attractive valuation compared to the broader pharmaceutical sector.
This unique positioning allows investors to capitalize on potential growth while benefiting from a favorable entry point.
Islamabad, April 22, 2026: Reinforcing its position as a leader in Diversity, Equity, and Inclusion…
Pakistan's Airports Authority announces plans to install advanced air traffic control systems at Karachi and…
Pakistan's federal budget for fiscal year 2026-27 is set to be presented in the first…
U.S. Air Force divers used an underwater remotely operated drone to recover one of six…
Iran's Islamic Revolutionary Guard Corps (IRGC) Navy announced on Wednesday it had seized two vessels…
Portland Trail Blazers secure upset win over San Antonio Spurs The Portland Trail Blazers defeated…
This website uses cookies.